Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,476 | 199 | 99.2% |
| Debt forgiveness | $27.78 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $238.91 | 16 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $216.59 | 5 | $0 (2024) |
| ABBVIE INC. | $190.76 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $187.49 | 11 | $0 (2024) |
| Incyte Corporation | $168.32 | 5 | $0 (2024) |
| Amgen Inc. | $140.03 | 8 | $0 (2023) |
| Daiichi Sankyo Inc. | $124.68 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $122.71 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $122.45 | 7 | $0 (2024) |
| Seagen Inc. | $117.33 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,161 | 62 | Incyte Corporation ($123.94) |
| 2023 | $1,194 | 63 | Pharmacosmos Therapeutics Inc. ($143.44) |
| 2022 | $568.94 | 37 | Janssen Biotech, Inc. ($64.29) |
| 2021 | $579.98 | 39 | Merck Sharp & Dohme Corporation ($59.28) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $23.33 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/14/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $17.45 | General |
| Category: Hematology | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: HEMATOLOGY | ||||||
| 09/28/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| Category: Hematology | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $18.78 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 09/06/2024 | TerSera Therapeutics LLC | Xermelo (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Oncology | ||||||
| 08/29/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Genentech USA, Inc. | Alecensa (Biological), Tecentriq | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: BioOncology | ||||||
| 08/15/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/08/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Oncology | ||||||
| 08/07/2024 | SOBI, INC | GAMIFANT (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: HEMATOLOGY | ||||||
| 08/07/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Oncology | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: Oncology | ||||||
| 06/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 69 | 142 | $21,430 | $4,893 |
| 2022 | 2 | 73 | 159 | $19,070 | $4,057 |
| 2021 | 2 | 50 | 109 | $18,985 | $4,132 |
| 2020 | 3 | 73 | 116 | $26,611 | $6,309 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 87 | $20,880 | $4,829 | 23.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 25 | 55 | $550.00 | $64.22 | 11.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 76 | $18,240 | $3,945 | 21.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 32 | 83 | $830.00 | $112.07 | 13.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 38 | 74 | $17,760 | $3,982 | 22.4% |
| 85610 | Blood test, clotting time | Office | 2021 | 12 | 35 | $1,225 | $150.15 | 12.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 34 | 67 | $16,080 | $3,549 | 22.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 35 | $8,611 | $1,970 | 22.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 14 | $1,920 | $789.04 | 41.1% |
About Marlene Schmitz
Marlene Schmitz is a Adult Health healthcare provider based in Springfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2008. The National Provider Identifier (NPI) number assigned to this provider is 1790937498.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marlene Schmitz has received a total of $3,503 in payments from pharmaceutical and medical device companies, with $1,161 received in 2024. These payments were reported across 201 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($3,476).
As a Medicare-enrolled provider, Schmitz has provided services to 265 Medicare beneficiaries, totaling 526 services with total Medicare billing of $19,391. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Springfield, NJ
- Active Since 10/14/2008
- Last Updated 05/20/2019
- Taxonomy Code 363LA2200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1790937498
Products in Payments
- KEYTRUDA (Biological) $187.49
- MONOFERRIC (Drug) $158.37
- DARZALEX (Biological) $139.07
- VENCLEXTA (Drug) $134.64
- Lenvima (Drug) $113.29
- Enhertu (Drug) $108.01
- PEMAZYRE (Drug) $103.83
- XARELTO (Drug) $88.61
- LONSURF (Drug) $83.68
- SCEMBLIX (Drug) $79.36
- Nubeqa (Drug) $78.22
- BRUKINSA (Drug) $77.53
- TUKYSA (Drug) $76.64
- IMBRUVICA (Drug) $73.72
- JAKAFI (Drug) $64.49
- LUMAKRAS (Drug) $63.36
- OPDIVO (Biological) $61.98
- clonoSEQ (Device) $60.84
- OXBRYTA (Drug) $57.38
- NINLARO (Drug) $55.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Springfield
Andrea Bushnell, Agnp-C, AGNP-C
Adult Health — Payments: $12,450
Mrs. Kimberly Koval, Rn, Msn, Apn-C, RN, MSN, APN-C
Adult Health — Payments: $11,360
Heidi Crull, Anp-Bc, ANP-BC
Adult Health — Payments: $7,347
Mrs. Jennifer Chieppa, Np-C, NP-C
Adult Health — Payments: $4,961
Marcy Bot-Baron, Anp, ANP
Adult Health — Payments: $3,493
Mrs. Brittney Veenstra, Anp, ANP
Adult Health — Payments: $3,084